Aurora Cannabis Inc. produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories, including valves, screens, etc.; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and ROAR Sports. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
IPO Year:
Exchange: NYSE
Website: auroramj.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/27/2026 | Buy | Canaccord Genuity | |
| 12/11/2024 | Buy | TD Cowen | |
| 2/9/2024 | Hold → Buy | Canaccord Genuity | |
| 9/21/2022 | Sell → Hold | Canaccord Genuity | |
| 6/24/2022 | Neutral → Overweight | Cantor Fitzgerald | |
| 6/6/2022 | Sell → Hold | Stifel | |
| 11/10/2021 | $9.60 → $10.75 | Neutral | Cantor Fitzgerald |
| 10/28/2021 | $9.50 → $9.60 | Neutral | Cantor Fitzgerald |
| 10/5/2021 | $8.30 → $9.50 | Neutral | Cantor Fitzgerald |
| 9/28/2021 | Sell → Neutral | MKM Partners |
6-K - AURORA CANNABIS INC (0001683541) (Filer)
6-K - AURORA CANNABIS INC (0001683541) (Filer)
6-K - AURORA CANNABIS INC (0001683541) (Filer)
40-F - AURORA CANNABIS INC (0001683541) (Filer)
6-K - AURORA CANNABIS INC (0001683541) (Filer)
6-K - AURORA CANNABIS INC (0001683541) (Filer)
6-K - AURORA CANNABIS INC (0001683541) (Filer)
6-K - AURORA CANNABIS INC (0001683541) (Filer)
6-K - AURORA CANNABIS INC (0001683541) (Filer)
6-K - AURORA CANNABIS INC (0001683541) (Filer)
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Canaccord Genuity initiated coverage of Aurora Cannabis with a rating of Buy
TD Cowen initiated coverage of Aurora Cannabis with a rating of Buy
Canaccord Genuity upgraded Aurora Cannabis from Hold to Buy
Canaccord Genuity upgraded Aurora Cannabis from Sell to Hold
Cantor Fitzgerald upgraded Aurora Cannabis from Neutral to Overweight
Stifel upgraded Aurora Cannabis from Sell to Hold
Cantor Fitzgerald reiterated coverage of Aurora Cannabis with a rating of Neutral and set a new price target of $10.75 from $9.60 previously
Cantor Fitzgerald reiterated coverage of Aurora Cannabis with a rating of Neutral and set a new price target of $9.60 from $9.50 previously
Cantor Fitzgerald reiterated coverage of Aurora Cannabis with a rating of Neutral and set a new price target of $9.50 from $8.30 previously
MKM Partners upgraded Aurora Cannabis from Sell to Neutral
Fastest customizable press release news feed in the world
NASDAQ | TSX: ACBThe Company makes history as the first and only cannabis company to ever receive this recognitionEDMONTON, AB, July 9, 2026 /CNW/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) ("Aurora" or the "Company"), the Canadian-based leading global medical cannabis company, has been awarded on TIME Canada's Best Companies 2026 list. This win reflects the Company's differentiated performance and commitment to industry excellence. To view the full award list, visit TIME.com. This prestigious award is presented by TIME in collaboration with Statista, the world-leading statistics portal and industry ranking provider. Canada'
Shareholders are encouraged to keep an eye out for their meeting materials and vote early – every vote matters, no matter how many shares you own.Shareholders who have questions or need assistance with voting their shares voting should contact Aurora's strategic advisor and proxy solicitation agent, Kingsdale Advisors by telephone at 1-800-749-9052 or by email at contactus@kingsdaleadvisors.com or visit www.MyAuroraVote.comEDMONTON, AB, July 8, 2026 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (TSX:ACB) (NASDAQ:ACB), a leading Canada-based global medical cannabis company, is pleased to announce that the management information circular (the "Circular") for the upcoming annual gen
NASDAQ | TSX: ACBAchieves Record Annual Global Medical Cannabis Net Revenue1 of $288.6 million, representing 18% YoY growthDelivers Record Annual Adjusted EBITDA1 of $53.8 million, representing 32% YoY growthCompletes Accretive Acquisition of Safari Flower Company in April, an established EU-GMP Manufacturer, adding Critical Capacity to Serve Growing Profitable International MarketsMaintains Strong Balance Sheet with ~$164.7 million of Cash, Short Term Investments and Cash Equivalents2 with no DebtEDMONTON, AB, June 11, 2026 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial an
NASDAQ | TSX: ACBEDMONTON, AB, May 28, 2026 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its fourth quarter and fiscal year 2026 on Thursday, June 11, 2026 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the fourth quarter and fiscal year 2026 before the opening of markets that same day. Conference Call DetailsDATE:Thursday, June 11, 2026TIME:8:00 a.m. Eastern Time | 6:00 a.m. Mountain TimeWEBCAST:
NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Europe's licensed cannabis industry is starting to look like one of the most exciting growth stories in the global cannabis market. What was once a fragmented, slow-moving sector is now gaining serious momentum as more countries open up medical cannabis programs, expand patient access, and create clearer licensing frameworks for producers and distributors. Germany continues to lead the charge after its cannabis reforms, but countries like the UK, Portugal, Italy, France, Switzerland, and the Czech Republic are also becoming major pieces of the puzzle. Investors and operators are paying close attention because
NASDAQ | TSX: ACBCanadian grant protects Aurora‑developed genetics bred through the company's advanced research and breeding programEDMONTON, AB, May 14, 2026 /CNW/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, announced today it has been granted Plant Breeders' Rights in Canada for two proprietary cannabis cultivars developed through its world-class breeding program. This certification gives Aurora the exclusive rights to grow, propagate, and sell finished products produced from these varieties. The two protected cult
NASDAQ | TSX: ACBQ1 launches reinforce Aurora's medical‑first strategy, expanding access to high‑quality products across multiple formatsScaled launches across Canada, Europe and Australia support growing demand in regulated international medical marketsContinued focus on quality, patient needs and reliable global supply through Aurora's extensive GMP‑certified networkEDMONTON, AB, April 28, 2026 /CNW/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian‑based leading global medical cannabis company, is significantly expanding its global medical cannabis portfolio, with new product launches rolling out across Canada, Europe and Australia. The company continues to shape the global
NASDAQ | TSX: ACBEDMONTON, AB, April 15, 2026 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, is pleased to announce it has acquired Safari Flower Company, an established EU GMP certified cannabis cultivator and manufacturer. Aggregate consideration is valued at $26.5 million, subject to customary adjustments, and inclusive of a cash payment of $2 million that is contingent on satisfaction of certain conditions (the "Transaction"). "The acquisition of Safari Flower Company marks an impor
NASDAQ | TSX: ACBThe Globe and Mail's Report on Business Women Lead Here List acknowledges Aurora's commitment to inclusive leadership at the executive levelEDMONTON, AB, March 30, 2026 /CNW/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian‑based leading global medical cannabis company, has been named on The Globe and Mail's 2026 Report on Business Women Lead Here list for the second consecutive year. The annual editorial benchmark recognizes publicly traded Canadian companies demonstrating strong executive‑level gender diversity, underscoring Aurora's continued commitment to inclusive leadership.
NASDAQ | TSX: ACBCanada's Largest Global Medical Cannabis Company to Discuss Growth Strategy, Key Trends and Market OpportunitiesEDMONTON, AB, Feb. 17, 2026 /CNW/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, will participate in TD Cowen's 46th Annual Health Care Conference in Boston, MA. Simona King, Chief Financial Officer at Aurora, will take part in a fireside chat and one-on-one meetings with investors on March 2, 2026. Conference DetailsDATE: Monday, March 2, 2026TIME: 11:10am Eastern Time | 9:10am Mountain TimeW
Live Leadership Updates
NASDAQ | TSX: ACB EDMONTON, AB, Dec. 8, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, announces Kerry Miller, a 35-year consumer packaged goods executive, as Managing Director for Australia and New Zealand, effective January 15, 2026. Kerry will be instrumental in driving growth in these key markets, drawing on decades of global experience in fast moving, regulated industries. "I'm excited to join Aurora at an inflection point in the company's global leadership and to work alongside a team dedicated
The collaboration will improve medical cannabis access and better serve patients across Australia NASDAQ | TSX: ACB EDMONTON, AB, Dec. 2, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, today announced the company's wholly owned subsidiary, MedReleaf Australia, has entered into a distribution partnership with Leafio, the wholesale distribution arm of Montu Australia. This strategic partnership will expand patient access to trusted, safe, and effective medical cannabis across Australia, while supporting healthcare professionals with educational resources. Leafio will serve as a wholesaler of Aurora's leading portfoli
VANCOUVER, British Columbia, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV:ROMJ) (OTCQX:ROMJF) ("Rubicon Organics", "Rubicon", or the "Company"), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, today announced the appointment of Glen Ibbott, a cannabis industry veteran and former Chief Financial Officer of Aurora Cannabis Inc. (TSX:ACB, NASDAQ:ACB) as its Chief Financial Officer and Corporate Secretary. "Over the past six months, Glen has demonstrated exceptional leadership, deep industry expertise, and a strong alignment with our values. His strategic insight and financial acumen have already made a significant impac
NASDAQ | TSX: ACB EDMONTON, AB, Aug. 8, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders (the "Meeting") held Friday August 8, 2025 by virtual webcast. The total number of shares represented by shareholders present in person (virtually) and by proxy at the Meeting was 17,736,521 common shares, representing 31.53% of Aurora's issued and outstanding common shares as of the record date.
VANCOUVER, British Columbia, May 15, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV:ROMJ) (OTCQX:ROMJF) ("Rubicon Organics" or the "Company"), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, today announced the appointment of Glen Ibbott, a cannabis industry veteran and former Chief Financial Officer of Aurora Cannabis Inc. (TSX:ACB, NASDAQ:ACB) as its Interim Chief Financial Officer. Janis Risbin, current CFO, will be stepping away from her full-time role effective today. She will remain in an advisory role over the next few months to ensure a smooth transition of responsibilities to Mr. Ibbott. "Glen's leadership at Aurora C
NASDAQ | TSX: ACB Outgoing Chairman Ron Funk appointed Lead Independent Director, as part of Board leadership transition EDMONTON, AB, Sept. 20, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced the appointments of CEO Miguel Martin to the additional role of Executive Chairman and outgoing Chairman Ron Funk as Lead Independent Director. Both appointments follow unanimous votes by Aurora's Board and are effective immediately. Mr. Martin has served as Chief Executiv
NASDAQ | TSX: ACB EDMONTON, AB, Aug. 12, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders (the "Meeting") held Friday August 9, 2024 by virtual webcast. The total number of shares represented by shareholders present in person (virtually) and by proxy at the Meeting was 14,855,306, representing 27.23% of Aurora's issued and outstanding common shares as of the record date. All of
NASDAQ | TSX: ACB Newly created directorship to be filled by Rajesh Uttamchandani EDMONTON, AB, May 15, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today the appointment of Rajesh Uttamchandani to the Company's Board of Directors (the "Board"), effective today. Mr. Uttamchandani joins the Board with notable expertise in strategy development, innovation, human capital and governance. His impressive career is characterized by executive level roles with leadin
DOVER, DE / ACCESSWIRE / April 10, 2024 / International Star, Inc. (OTC:ILST) (the "Company" or "ILST") is pleased to announce the appointment of Todd Masse as its new Chief Executive Officer effective April 3, 2024. Mr. Masse has over 25 years of extensive experience managing and operating businesses across various industries, including startups, consumer-packaged goods, technology, and real estate. Since 2015, Mr. Masse has been a key figure in the cannabis industry, serving as both an entrepreneur and operator. His visionary leadership and innovative approach have driven growth and success in this rapidly evolving sector.Mr. Masse's achievements include serving as President of Cannabis C
NASDAQ | TSX: ACB New brand promises great product and taste. First lineup includes flavour packed 50% THC pre-rolls and 1,000mg vapes EDMONTON, AB , Sept. 19, 2023 /PRNewswire/ - Aurora Cannabis (NASDAQ:ACB) (TSX:ACB), the Canadian company opening the world to cannabis, is launching a bold new brand, TASTY'S, to the Canadian adult market, designed to deliver on taste, potency, and price. Anchored by a disruptive brand identity, TASTY'S celebrates its market arrival today in Toronto at Hall of Flowers, a premier cannabis trade show. The TASTY'S brand is available for cannabis enthusiasts, including buyers and budtenders, to experience and see firsthand that TASTY'S promises to deliver high
This live feed shows all institutional transactions in real time.
SC 13G/A - AURORA CANNABIS INC (0001683541) (Subject)
SC 13G - AURORA CANNABIS INC (0001683541) (Subject)
SC 13G/A - AURORA CANNABIS INC (0001683541) (Subject)
SC 13G/A - AURORA CANNABIS INC (0001683541) (Subject)
Live finance-specific insights
NASDAQ | TSX: ACBAchieves Record Annual Global Medical Cannabis Net Revenue1 of $288.6 million, representing 18% YoY growthDelivers Record Annual Adjusted EBITDA1 of $53.8 million, representing 32% YoY growthCompletes Accretive Acquisition of Safari Flower Company in April, an established EU-GMP Manufacturer, adding Critical Capacity to Serve Growing Profitable International MarketsMaintains Strong Balance Sheet with ~$164.7 million of Cash, Short Term Investments and Cash Equivalents2 with no DebtEDMONTON, AB, June 11, 2026 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial an
NASDAQ | TSX: ACBEDMONTON, AB, May 28, 2026 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its fourth quarter and fiscal year 2026 on Thursday, June 11, 2026 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the fourth quarter and fiscal year 2026 before the opening of markets that same day. Conference Call DetailsDATE:Thursday, June 11, 2026TIME:8:00 a.m. Eastern Time | 6:00 a.m. Mountain TimeWEBCAST:
NASDAQ | TSX: ACB Expands YoY Total Net Revenue1 by 7% to $94.2 million, with Global Medical Cannabis Net Revenue1 Increasing by 12% to a Record $76.2 millionDelivers Adjusted EBITDA1 of $18.5 million and Adjusted Net Income1 of $7.2 millionGenerates Free Cash Flow1 of $15.5 million Maintains Strong Balance Sheet with $154.4 million of Cash2 and Short-Term Investments, and a Debt-Free Cannabis Business2EDMONTON, AB, Feb. 4, 2026 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the third quarter 2026 period ending December 31, 2025.
NASDAQ | TSX: ACB EDMONTON, AB, Jan. 21, 2026 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its third quarter 2026 on Wednesday, February 4, 2026 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the third quarter 2026 before the opening of markets that same day. Conference Call Details DATE: Wednesday, February 4, 2026 TIME: 8:00 a.m. Eastern Time |
Expands YoY Global Medical Cannabis Net Revenue1 by 15% to Record $70.5 millionIncreases International Medical Cannabis Net Revenue1 by 22% to Record $42.7 million, with leadership positions across key marketsDelivers Adjusted EBITDA1 growth of 52%, reaching $15.4 million Maintains Strong Balance Sheet with $141.9 million of Cash and Debt-Free Cannabis Business2NASDAQ | TSX: ACB EDMONTON, AB, Nov. 5, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the second quarter 2026 period ending September 30, 2025.
NASDAQ | TSX: ACB EDMONTON, AB, Oct. 22, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its second quarter 2026 on Wednesday, November 5, 2025 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the second quarter 2026 before the opening of markets that same day. Conference Call Details DATE: Wednesday, November 5, 2025 TIME: 8:00 a.m. Easte
Canada's Largest Medical Cannabis Company to Discuss Strategy, Industry Trends, and Long-Term Growth Outlook EDMONTON, ALBERTA, Aug. 7, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, will participate in Canaccord Genuity 45th Annual Growth Conference in Boston, MA. Simona King, Chief Financial Officer at Aurora, will take part in a fireside chat on August 13th at 1:30pm EST and conduct one-on-one meetings with investors throughout the day. The discussion will cover Aurora's strategic direction, recen
NASDAQ | TSX: ACB Expands YoY Global Medical Cannabis Net Revenue1 by 37% to $64.8 million, while increasing International Medical Cannabis Net Revenue1 by 85% to $37.1 millionDelivers Adjusted EBITDA1 growth in excess of 200%, reaching $10.8 million Generates Positive Free Cash Flow1 of $9.2 million, representing significant YoY growth of 42% Maintains Strong Balance Sheet with ~$186.0 million of Cash and Debt-Free Cannabis Business2EDMONTON, AB, Aug. 6, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the first quarter 2026 period end
NASDAQ | TSX: ACB EDMONTON, AB, July 23, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its first quarter 2026 on Wednesday, August 6, 2025 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the first quarter 2026 before the opening of markets that same day. Conference Call Details DATE: Wednesday, August 6, 2025 TIME: 8:00 a.m. Easte
NASDAQ | TSX: ACB Achieves Record Annual Global Medical Cannabis Net Revenue1 of $244.4 million, representing 39% YoY growthDelivers Record Adjusted EBITDA1 of $49.7 million, representing 261% YoY growthGenerates Annual Positive Free Cash Flow1 of $9.9 million Sustains Strong Balance Sheet with ~$185.3 million of Cash and Debt-Free Cannabis Business2EDMONTON, AB, June 18, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the fourth quarter and fiscal year 2025 periods ending March 31, 2025.